Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction - Sho, Takuya; Suda, Goki; Nagasaka, Atsushi; Yamamoto, Yoshiya; Furuya, Ken; Kumagai, Kenichi; Uebayashi, Minoru; Terashita, Katsumi; Kobayashi, Tomoe; Tsunematsu, Izumi; Onodera, Manabu; Meguro, Takashi; et al. (Hepatology research, 2018)
Keywords: Clinical trials; direct‐acting antiviral; Fibrosis; Genotype & phenotype; Genotypes; Hemoglobin; Hepatitis; Hepatitis C; hepatitis C virus; Liver; Multivariate analysis; Patients; Renal function; renal impairment; Ribavirin; Safety; sofosbuvir; sofosbuvir; hepatitis C virus; direct-acting antiviral; ribavirin; renal impairment